SCHEMBL20750037

SCHEMBL20750037

CNCCNC(=O)c1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDAH1 O94760 1/20 0.51
▸ HSP90AA1 P07900 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HPGD P15428 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ CACNA1B Q00975 1/20 0.50
▸ APBA1 Q02410 1/20 0.50
▸ MAPT P10636 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ MGLL Q99685 11/20 0.46
▸ FAAH O00519 4/20 0.46
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ PKM P14618 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17208726 0.86 HTT (0.55) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL17235983 0.83 CYP1A2 (0.57) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL17208725 0.83 DDAH1 (0.53) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL17231644 0.83 HPGD (0.58) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL14479038 0.81 DDAH1 (0.58) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL14000501 0.80 DDAH1 (0.61) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL28901118 0.78 DDAH1 (0.59) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL12945871 0.78 ADAM17 (0.45) HSP90AA1TDP1ALDH1A1HTTMAPT
SCHEMBL30831285 0.78 SMN1; SMN2 (0.51) DDAH1HSP90AA1NPSR1TDP1ALDH1A1
SCHEMBL3339259 0.77 DDAH1 (0.61) DDAH1HSP90AA1NPSR1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10226535-B2 Auristatin compounds and conjugates thereof MERSANA THERAPEUTICS, INC. (US) 2019-03-12 — — US disclosed
EP-2928503-B1 CONJUGATES OF AURISTATIN COMPOUNDS MERSANA THERAPEUTICS INC (US) 2019-02-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10226535-B2 Auristatin compounds and conjugates thereof PBRM1, AURKB, ILK DDAH1 1724/4885HSP90AA1 2489/4885NPSR1 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback